Key result
Fasting serum apolipoprotein B-48 levels were significantly higher in patients with coronary artery disease compared to non-CAD subjects (6.9 vs 3.9 μg/mL, P<0.0001).
Why the study?
Does fasting serum apolipoprotein B-48 correlate with the prevalence of coronary artery disease?
Population
189 subjects who received a coronary angiography and did not take any lipid-lowering drugs, including 96…
Comparison
High fasting serum apolipoprotein B-48 levels vs Low fasting serum apolipoprotein B-48 levels
Design
Case-control
Authors
Loading...
Associated with prevalent CAD in case-control data; leaves open incremental prognostic value beyond standard lipids.
Case-Control (n=189)
Does fasting serum apolipoprotein B-48 correlate with the prevalence of coronary artery disease?
Absolute Event Rate: 6.9% vs 3.9%
p-value: p=<0.0001
Fasting serum apolipoprotein B-48 levels are significantly elevated in patients with coronary artery disease and correlate with its prevalence, especially when clustered with other coronary risk factors.
Masuda et al. (2012) conducted a case-control in Coronary artery disease (n=189). Coronary artery disease (CAD) vs. Non-CAD subjects was evaluated on Fasting serum apolipoprotein B-48 concentration (μg/mL) (p=<0.0001). Fasting serum apolipoprotein B-48 levels were significantly higher in patients with coronary artery disease compared to non-CAD subjects (6.9 vs 3.9 μg/mL, P<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: